# AbbVie operating income entity: /record/abbvie.md predicate: operating_income page: /record/abbvie/operating_income as_of: 2026-11-08 cite: AsOf. "AbbVie quarterly operating income: 6,267,000,000 United States dollar", as of 2026-09-30. Claim clm_5AF8A08D6F94, https://asof.is/claim/clm_5AF8A08D6F94, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm. As of November 8, 2026, the latest operating income figure on the AsOf record for AbbVie is $6.27 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). AbbVie's latest full-year operating income is $15.08 billion, dated December 31, 2025, from a primary source (sec.gov); the two periods are kept apart, never compared. 15 claims on AbbVie's operating income, 1 open and 14 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Latest operating income The newest figure for a shorter period, the quarter ended September 30, 2026: a quarterly_operating_income claim, kept apart from the full-year series. - [AbbVie](/record/abbvie.md) | quarterly_operating_income | 6,267,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_5AF8A08D6F94](/claim/clm_5AF8A08D6F94.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm ## Latest full-year operating income What the record asserts on 2026-11-08. - [AbbVie](/record/abbvie.md) | operating_income | 15,075,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_D4AF640165D7](/claim/clm_D4AF640165D7.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [AbbVie](/record/abbvie.md) | operating_income | 3,620,000,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_2E2748C2CF51](/claim/clm_2E2748C2CF51.md) | [clm_3C7DE622672F](/claim/clm_3C7DE622672F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 5,817,000,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_A9B273E426B3](/claim/clm_A9B273E426B3.md) | [clm_2E2748C2CF51](/claim/clm_2E2748C2CF51.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 5,664,000,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_5420B85B9EF4](/claim/clm_5420B85B9EF4.md) | [clm_A9B273E426B3](/claim/clm_A9B273E426B3.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746914001154/0001047469-14-001154-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 3,411,000,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_3F2A5C2764AA](/claim/clm_3F2A5C2764AA.md) | [clm_5420B85B9EF4](/claim/clm_5420B85B9EF4.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746915000995/0001047469-15-000995-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 7,537,000,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_D0B092E67442](/claim/clm_D0B092E67442.md) | [clm_3F2A5C2764AA](/claim/clm_3F2A5C2764AA.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000104746916010239/0001047469-16-010239-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 9,384,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_386A79CBE5AB](/claim/clm_386A79CBE5AB.md) | [clm_D0B092E67442](/claim/clm_D0B092E67442.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000004/0001551152-17-000004-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 9,592,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_C605181FAEA0](/claim/clm_C605181FAEA0.md) | [clm_386A79CBE5AB](/claim/clm_386A79CBE5AB.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000014/0001551152-18-000014-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 6,383,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_CDA568F800DA](/claim/clm_CDA568F800DA.md) | [clm_C605181FAEA0](/claim/clm_C605181FAEA0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000008/0001551152-19-000008-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 12,983,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_741BF6260BB0](/claim/clm_741BF6260BB0.md) | [clm_CDA568F800DA](/claim/clm_CDA568F800DA.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000007/0001551152-20-000007-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 11,363,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_312A48E2B5D0](/claim/clm_312A48E2B5D0.md) | [clm_741BF6260BB0](/claim/clm_741BF6260BB0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000008/0001551152-21-000008-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 17,924,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_810E9C4E1BC6](/claim/clm_810E9C4E1BC6.md) | [clm_312A48E2B5D0](/claim/clm_312A48E2B5D0.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000007/0001551152-22-000007-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 18,117,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_5D66F3208260](/claim/clm_5D66F3208260.md) | [clm_810E9C4E1BC6](/claim/clm_810E9C4E1BC6.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000011/0001551152-23-000011-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 12,757,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_7198B453007F](/claim/clm_7198B453007F.md) | [clm_5D66F3208260](/claim/clm_5D66F3208260.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000011/0001551152-24-000011-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 9,137,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_D4AF640165D7](/claim/clm_D4AF640165D7.md) | [clm_7198B453007F](/claim/clm_7198B453007F.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/0001551152-25-000020-index.htm - [AbbVie](/record/abbvie.md) | operating_income | 15,075,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_D4AF640165D7](/claim/clm_D4AF640165D7.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm ## What replaced what - $3.62 billion (2011-12-31 to 2012-12-31, [clm_3C7DE622672F](/claim/clm_3C7DE622672F.md)) was replaced by $5.82 billion from 2012-12-31 ([clm_2E2748C2CF51](/claim/clm_2E2748C2CF51.md)) - $5.82 billion (2012-12-31 to 2013-12-31, [clm_2E2748C2CF51](/claim/clm_2E2748C2CF51.md)) was replaced by $5.66 billion from 2013-12-31 ([clm_A9B273E426B3](/claim/clm_A9B273E426B3.md)) - $5.66 billion (2013-12-31 to 2014-12-31, [clm_A9B273E426B3](/claim/clm_A9B273E426B3.md)) was replaced by $3.41 billion from 2014-12-31 ([clm_5420B85B9EF4](/claim/clm_5420B85B9EF4.md)) - $3.41 billion (2014-12-31 to 2015-12-31, [clm_5420B85B9EF4](/claim/clm_5420B85B9EF4.md)) was replaced by $7.54 billion from 2015-12-31 ([clm_3F2A5C2764AA](/claim/clm_3F2A5C2764AA.md)) - $7.54 billion (2015-12-31 to 2016-12-31, [clm_3F2A5C2764AA](/claim/clm_3F2A5C2764AA.md)) was replaced by $9.38 billion from 2016-12-31 ([clm_D0B092E67442](/claim/clm_D0B092E67442.md)) - $9.38 billion (2016-12-31 to 2017-12-31, [clm_D0B092E67442](/claim/clm_D0B092E67442.md)) was replaced by $9.59 billion from 2017-12-31 ([clm_386A79CBE5AB](/claim/clm_386A79CBE5AB.md)) - $9.59 billion (2017-12-31 to 2018-12-31, [clm_386A79CBE5AB](/claim/clm_386A79CBE5AB.md)) was replaced by $6.38 billion from 2018-12-31 ([clm_C605181FAEA0](/claim/clm_C605181FAEA0.md)) - $6.38 billion (2018-12-31 to 2019-12-31, [clm_C605181FAEA0](/claim/clm_C605181FAEA0.md)) was replaced by $12.98 billion from 2019-12-31 ([clm_CDA568F800DA](/claim/clm_CDA568F800DA.md)) - $12.98 billion (2019-12-31 to 2020-12-31, [clm_CDA568F800DA](/claim/clm_CDA568F800DA.md)) was replaced by $11.36 billion from 2020-12-31 ([clm_741BF6260BB0](/claim/clm_741BF6260BB0.md)) - $11.36 billion (2020-12-31 to 2021-12-31, [clm_741BF6260BB0](/claim/clm_741BF6260BB0.md)) was replaced by $17.92 billion from 2021-12-31 ([clm_312A48E2B5D0](/claim/clm_312A48E2B5D0.md)) - $17.92 billion (2021-12-31 to 2022-12-31, [clm_312A48E2B5D0](/claim/clm_312A48E2B5D0.md)) was replaced by $18.12 billion from 2022-12-31 ([clm_810E9C4E1BC6](/claim/clm_810E9C4E1BC6.md)) - $18.12 billion (2022-12-31 to 2023-12-31, [clm_810E9C4E1BC6](/claim/clm_810E9C4E1BC6.md)) was replaced by $12.76 billion from 2023-12-31 ([clm_5D66F3208260](/claim/clm_5D66F3208260.md)) - $12.76 billion (2023-12-31 to 2024-12-31, [clm_5D66F3208260](/claim/clm_5D66F3208260.md)) was replaced by $9.14 billion from 2024-12-31 ([clm_7198B453007F](/claim/clm_7198B453007F.md)) - $9.14 billion (2024-12-31 to 2025-12-31, [clm_7198B453007F](/claim/clm_7198B453007F.md)) was replaced by $15.08 billion from 2025-12-31 ([clm_D4AF640165D7](/claim/clm_D4AF640165D7.md)) ## Questions this record answers ### What is AbbVie's current operating income? The latest figure on the record is $6.27 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). The latest full-year figure is $15.08 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts both as of November 8, 2026. ### What was AbbVie's operating income for the quarter ended September 30, 2026? $6.27 billion for the quarter ended September 30, 2026, dated September 30, 2026, from a primary source (sec.gov) (status valid, confidence 0.95). ### When did AbbVie's operating income last change? The latest value on the record is $15.08 billion, dated December 31, 2025; before it the record holds $9.14 billion, dated December 31, 2024 and closed on December 31, 2025. ### What was AbbVie's operating income before $15.08 billion? $9.14 billion, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/abbvie/operating_income (markdown: /record/abbvie/operating_income.md) - Entity twin: /record/abbvie.md ยท timeline: /timelines/abbvie.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.